<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://physrev.physiology.org">
<title>Physiological Reviews current issue</title>
<link>http://physrev.physiology.org</link>
<description>Physiological Reviews RSS feed -- current issue</description>
<prism:eIssn>1522-1210</prism:eIssn>
<prism:coverDisplayDate>Jan  1 2010 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Physiological Reviews</prism:publicationName>
<prism:issn>0031-9333</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/1?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/23?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/47?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/113?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/179?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/207?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/259?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/291?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/90/1/367?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://physrev.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://physrev.physiology.org/icons/banner/title.gif">
<title>Physiological Reviews</title>
<url>http://physrev.physiology.org/icons/banner/title.gif</url>
<link>http://physrev.physiology.org</link>
</image>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/1?rss=1">
<title><![CDATA[The Fox Genes in the Liver: From Organogenesis to Functional Integration]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/1?rss=1</link>
<description><![CDATA[
<p>Formation and function of the liver are highly controlled, essential processes. Multiple signaling pathways and transcriptional regulatory networks cooperate in this complex system. The evolutionarily conserved FOX, for Forkhead bOX, class of transcriptional regulators is critical to many aspects of liver development and function. The FOX proteins are small, mostly monomeric DNA binding factors containing the so-called winged helix DNA binding motif that distinguishes them from other classes of transcription factors. We discuss the biochemical and genetic roles of Foxa, Foxl1, Foxm1, and Foxo, as these have been shown to regulate many processes throughout the life of the organ, controlling both formation and function of the liver.</p>
]]></description>
<dc:creator><![CDATA[Le lay, J., Kaestner, K. H.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00018.2009</dc:identifier>
<dc:title><![CDATA[The Fox Genes in the Liver: From Organogenesis to Functional Integration]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>22</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/23?rss=1">
<title><![CDATA[Metabolic Effects of Fructose and the Worldwide Increase in Obesity]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/23?rss=1</link>
<description><![CDATA[
<p>While virtually absent in our diet a few hundred years ago, fructose has now become a major constituent of our modern diet. Our main sources of fructose are sucrose from beet or cane, high fructose corn syrup, fruits, and honey. Fructose has the same chemical formula as glucose (C<SUB>6</SUB>H<SUB>12</SUB>O<SUB>6</SUB>), but its metabolism differs markedly from that of glucose due to its almost complete hepatic extraction and rapid hepatic conversion into glucose, glycogen, lactate, and fat. Fructose was initially thought to be advisable for patients with diabetes due to its low glycemic index. However, chronically high consumption of fructose in rodents leads to hepatic and extrahepatic insulin resistance, obesity, type 2 diabetes mellitus, and high blood pressure. The evidence is less compelling in humans, but high fructose intake has indeed been shown to cause dyslipidemia and to impair hepatic insulin sensitivity. Hepatic de novo lipogenesis and lipotoxicity, oxidative stress, and hyperuricemia have all been proposed as mechanisms responsible for these adverse metabolic effects of fructose. Although there is compelling evidence that very high fructose intake can have deleterious metabolic effects in humans as in rodents, the role of fructose in the development of the current epidemic of metabolic disorders remains controversial. Epidemiological studies show growing evidence that consumption of sweetened beverages (containing either sucrose or a mixture of glucose and fructose) is associated with a high energy intake, increased body weight, and the occurrence of metabolic and cardiovascular disorders. There is, however, no unequivocal evidence that fructose intake at moderate doses is directly related with adverse metabolic effects. There has also been much concern that consumption of free fructose, as provided in high fructose corn syrup, may cause more adverse effects than consumption of fructose consumed with sucrose. There is, however, no direct evidence for more serious metabolic consequences of high fructose corn syrup versus sucrose consumption.</p>
]]></description>
<dc:creator><![CDATA[Tappy, L., Le, K.-A.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00019.2009</dc:identifier>
<dc:title><![CDATA[Metabolic Effects of Fructose and the Worldwide Increase in Obesity]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>46</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>23</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/47?rss=1">
<title><![CDATA[Pathophysiology of Sleep Apnea]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/47?rss=1</link>
<description><![CDATA[
<p>Sleep-induced apnea and disordered breathing refers to intermittent, cyclical cessations or reductions of airflow, with or without obstructions of the upper airway (OSA). In the presence of an anatomically compromised, collapsible airway, the sleep-induced loss of compensatory tonic input to the upper airway dilator muscle motor neurons leads to collapse of the pharyngeal airway. In turn, the ability of the sleeping subject to compensate for this airway obstruction will determine the degree of cycling of these events. Several of the classic neurotransmitters and a growing list of neuromodulators have now been identified that contribute to neurochemical regulation of pharyngeal motor neuron activity and airway patency. Limited progress has been made in developing pharmacotherapies with acceptable specificity for the treatment of sleep-induced airway obstruction. We review three types of major long-term sequelae to severe OSA that have been assessed in humans through use of continuous positive airway pressure (CPAP) treatment and in animal models via long-term intermittent hypoxemia (IH): <I>1</I>) cardiovascular. The evidence is strongest to support daytime systemic hypertension as a consequence of severe OSA, with less conclusive effects on pulmonary hypertension, stroke, coronary artery disease, and cardiac arrhythmias. The underlying mechanisms mediating hypertension include enhanced chemoreceptor sensitivity causing excessive daytime sympathetic vasoconstrictor activity, combined with overproduction of superoxide ion and inflammatory effects on resistance vessels. <I>2</I>) Insulin sensitivity and homeostasis of glucose regulation are negatively impacted by both intermittent hypoxemia and sleep disruption, but whether these influences of OSA are sufficient, independent of obesity, to contribute significantly to the "metabolic syndrome" remains unsettled. <I>3</I>) Neurocognitive effects include daytime sleepiness and impaired memory and concentration. These effects reflect hypoxic-induced "neural injury." We discuss future research into understanding the pathophysiology of sleep apnea as a basis for uncovering newer forms of treatment of both the ventilatory disorder and its multiple sequelae.</p>
]]></description>
<dc:creator><![CDATA[Dempsey, J. A., Veasey, S. C., Morgan, B. J., O'Donnell, C. P.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00043.2008</dc:identifier>
<dc:title><![CDATA[Pathophysiology of Sleep Apnea]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>112</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>47</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/113?rss=1">
<title><![CDATA[Sarcoplasmic Reticulum Function in Smooth Muscle]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/113?rss=1</link>
<description><![CDATA[
<p>The sarcoplasmic reticulum (SR) of smooth muscles presents many intriguing facets and questions concerning its roles, especially as these change with development, disease, and modulation of physiological activity. The SR's function was originally perceived to be synthetic and then that of a Ca store for the contractile proteins, acting as a Ca amplification mechanism as it does in striated muscles. Gradually, as investigators have struggled to find a convincing role for Ca-induced Ca release in many smooth muscles, a role in controlling excitability has emerged. This is the Ca spark/spontaneous transient outward current coupling mechanism which reduces excitability and limits contraction. Release of SR Ca occurs in response to inositol 1,4,5-trisphosphate, Ca, and nicotinic acid adenine dinucleotide phosphate, and depletion of SR Ca can initiate Ca entry, the mechanism of which is being investigated but seems to involve Stim and Orai as found in nonexcitable cells. The contribution of the elemental Ca signals from the SR, sparks and puffs, to global Ca signals, i.e., Ca waves and oscillations, is becoming clearer but is far from established. The dynamics of SR Ca release and uptake mechanisms are reviewed along with the control of luminal Ca. We review the growing list of the SR's functions that still includes Ca storage, contraction, and relaxation but has been expanded to encompass Ca homeostasis, generating local and global Ca signals, and contributing to cellular microdomains and signaling in other organelles, including mitochondria, lysosomes, and the nucleus. For an integrated approach, a review of aspects of the SR in health and disease and during development and aging are also included. While the sheer versatility of smooth muscle makes it foolish to have a "one model fits all" approach to this subject, we have tried to synthesize conclusions wherever possible.</p>
]]></description>
<dc:creator><![CDATA[Wray, S., Burdyga, T.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00018.2008</dc:identifier>
<dc:title><![CDATA[Sarcoplasmic Reticulum Function in Smooth Muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>178</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>113</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/179?rss=1">
<title><![CDATA[Lens Gap Junctions in Growth, Differentiation, and Homeostasis]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/179?rss=1</link>
<description><![CDATA[
<p>The cells of most mammalian organs are connected by groups of cell-to-cell channels called gap junctions. Gap junction channels are made from the connexin (Cx) family of proteins. There are at least 20 isoforms of connexins, and most tissues express more than 1 isoform. The lens is no exception, as it expresses three isoforms: Cx43, Cx46, and Cx50. A common role for all gap junctions, regardless of their Cx composition, is to provide a conduit for ion flow between cells, thus creating a syncytial tissue with regard to intracellular voltage and ion concentrations. Given this rather simple role of gap junctions, a persistent question has been: Why are there so many Cx isoforms and why do tissues express more than one isoform? Recent studies of lens Cx knockout (KO) and knock in (KI) lenses have begun to answer these questions. To understand these roles, one must first understand the physiological requirements of the lens. We therefore first review the development and structure of the lens, its numerous transport systems, how these systems are integrated to generate the lens circulation, the roles of the circulation in lens homeostasis, and finally the roles of lens connexins in growth, development, and the lens circulation.</p>
]]></description>
<dc:creator><![CDATA[Mathias, R. T., White, T. W., Gong, X.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00034.2009</dc:identifier>
<dc:title><![CDATA[Lens Gap Junctions in Growth, Differentiation, and Homeostasis]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>206</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>179</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/207?rss=1">
<title><![CDATA[Myocardial Fatty Acid Metabolism in Health and Disease]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/207?rss=1</link>
<description><![CDATA[
<p>There is a constant high demand for energy to sustain the continuous contractile activity of the heart, which is met primarily by the &beta;-oxidation of long-chain fatty acids. The control of fatty acid &beta;-oxidation is complex and is aimed at ensuring that the supply and oxidation of the fatty acids is sufficient to meet the energy demands of the heart. The metabolism of fatty acids via &beta;-oxidation is not regulated in isolation; rather, it occurs in response to alterations in contractile work, the presence of competing substrates (i.e., glucose, lactate, ketones, amino acids), changes in hormonal milieu, and limitations in oxygen supply. Alterations in fatty acid metabolism can contribute to cardiac pathology. For instance, the excessive uptake and &beta;-oxidation of fatty acids in obesity and diabetes can compromise cardiac function. Furthermore, alterations in fatty acid &beta;-oxidation both during and after ischemia and in the failing heart can also contribute to cardiac pathology. This paper reviews the regulation of myocardial fatty acid &beta;-oxidation and how alterations in fatty acid &beta;-oxidation can contribute to heart disease. The implications of inhibiting fatty acid &beta;-oxidation as a potential novel therapeutic approach for the treatment of various forms of heart disease are also discussed.</p>
]]></description>
<dc:creator><![CDATA[Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., Stanley, W. C.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:18 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00015.2009</dc:identifier>
<dc:title><![CDATA[Myocardial Fatty Acid Metabolism in Health and Disease]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>258</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>207</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/259?rss=1">
<title><![CDATA[Regulation of the Actin Cytoskeleton-Plasma Membrane Interplay by Phosphoinositides]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/259?rss=1</link>
<description><![CDATA[
<p>The plasma membrane and the underlying cortical actin cytoskeleton undergo continuous dynamic interplay that is responsible for many essential aspects of cell physiology. Polymerization of actin filaments against cellular membranes provides the force for a number of cellular processes such as migration, morphogenesis, and endocytosis. Plasma membrane phosphoinositides (especially phosphatidylinositol bis- and trisphosphates) play a central role in regulating the organization and dynamics of the actin cytoskeleton by acting as platforms for protein recruitment, by triggering signaling cascades, and by directly regulating the activities of actin-binding proteins. Furthermore, a number of actin-associated proteins, such as BAR domain proteins, are capable of directly deforming phosphoinositide-rich membranes to induce plasma membrane protrusions or invaginations. Recent studies have also provided evidence that the actin cytoskeleton-plasma membrane interactions are misregulated in a number of pathological conditions such as cancer and during pathogen invasion. Here, we summarize the wealth of knowledge on how the cortical actin cytoskeleton is regulated by phosphoinositides during various cell biological processes. We also discuss the mechanisms by which interplay between actin dynamics and certain membrane deforming proteins regulate the morphology of the plasma membrane.</p>
]]></description>
<dc:creator><![CDATA[Saarikangas, J., Zhao, H., Lappalainen, P.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:19 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00036.2009</dc:identifier>
<dc:title><![CDATA[Regulation of the Actin Cytoskeleton-Plasma Membrane Interplay by Phosphoinositides]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>289</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>259</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/291?rss=1">
<title><![CDATA[Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/291?rss=1</link>
<description><![CDATA[
<p>Inwardly rectifying K<sup>+</sup> (Kir) channels allow K<sup>+</sup> to move more easily into rather than out of the cell. They have diverse physiological functions depending on their type and their location. There are seven Kir channel subfamilies that can be classified into four functional groups: classical Kir channels (Kir2.x) are constitutively active, G protein-gated Kir channels (Kir3.x) are regulated by G protein-coupled receptors, ATP-sensitive K<sup>+</sup> channels (Kir6.x) are tightly linked to cellular metabolism, and K<sup>+</sup> transport channels (Kir1.x, Kir4.x, Kir5.x, and Kir7.x). Inward rectification results from pore block by intracellular substances such as Mg<sup>2+</sup> and polyamines. Kir channel activity can be modulated by ions, phospholipids, and binding proteins. The basic building block of a Kir channel is made up of two transmembrane helices with cytoplasmic NH<SUB>2</SUB> and COOH termini and an extracellular loop which folds back to form the pore-lining ion selectivity filter. In vivo, functional Kir channels are composed of four such subunits which are either homo- or heterotetramers. Gene targeting and genetic analysis have linked Kir channel dysfunction to diverse pathologies. The crystal structure of different Kir channels is opening the way to understanding the structure-function relationships of this simple but diverse ion channel family.</p>
]]></description>
<dc:creator><![CDATA[Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., Kurachi, Y.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:19 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00021.2009</dc:identifier>
<dc:title><![CDATA[Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>366</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>291</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/90/1/367?rss=1">
<title><![CDATA[Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/90/1/367?rss=1</link>
<description><![CDATA[
<p>Long-chain fatty acids and lipids serve a wide variety of functions in mammalian homeostasis, particularly in the formation and dynamic properties of biological membranes and as fuels for energy production in tissues such as heart and skeletal muscle. On the other hand, long-chain fatty acid metabolites may exert toxic effects on cellular functions and cause cell injury. Therefore, fatty acid uptake into the cell and intracellular handling need to be carefully controlled. In the last few years, our knowledge of the regulation of cellular fatty acid uptake has dramatically increased. Notably, fatty acid uptake was found to occur by a mechanism that resembles that of cellular glucose uptake. Thus, following an acute stimulus, particularly insulin or muscle contraction, specific fatty acid transporters translocate from intracellular stores to the plasma membrane to facilitate fatty acid uptake, just as these same stimuli recruit glucose transporters to increase glucose uptake. This regulatory mechanism is important to clear lipids from the circulation postprandially and to rapidly facilitate substrate provision when the metabolic demands of heart and muscle are increased by contractile activity. Studies in both humans and animal models have implicated fatty acid transporters in the pathogenesis of diseases such as the progression of obesity to insulin resistance and type 2 diabetes. As a result, membrane fatty acid transporters are now being regarded as a promising therapeutic target to redirect lipid fluxes in the body in an organ-specific fashion.</p>
]]></description>
<dc:creator><![CDATA[Glatz, J. F. C., Luiken, J. J. F. P., Bonen, A.]]></dc:creator>
<dc:date>Tue, 19 Jan 2010 08:34:19 PST</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00003.2009</dc:identifier>
<dc:title><![CDATA[Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>90</prism:volume>
<prism:endingPage>417</prism:endingPage>
<prism:publicationDate>2010-01-01</prism:publicationDate>
<prism:startingPage>367</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

</rdf:RDF>